3,4-dihydroxyphenylacetic acid has been researched along with dopamine quinone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, GW; Qi, Z; Voit, EO | 1 |
| Herrera-Mundo, N; Sitges, M | 1 |
| Baranyi, M; Gagov, H; Kalfin, R; Petkova-Kirova, P; Rakovska, A; Windisch, K | 1 |
| Goldstein, DS; Isonaka, R; Jinsmaa, Y; Sharabi, Y | 1 |
4 other study(ies) available for 3,4-dihydroxyphenylacetic acid and dopamine quinone
| Article | Year |
|---|---|
Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals.
Topics: 3,4-Dihydroxyphenylacetic Acid; Catechol O-Methyltransferase; Computer Simulation; Dopamine; Dopamine Plasma Membrane Transport Proteins; Extracellular Space; Humans; Iron; Models, Neurological; Monoamine Oxidase; Monte Carlo Method; Neurons; Quinones; Vesicular Monoamine Transport Proteins | 2009 |
Mechanisms underlying striatal vulnerability to 3-nitropropionic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Corpus Striatum; Dopamine; Exocytosis; In Vitro Techniques; Male; Motor Activity; Nerve Endings; Neurotoxins; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Reactive Oxygen Species; Synaptosomes | 2010 |
Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Electric Stimulation; Extracellular Space; Homovanillic Acid; Humans; Male; Mice; Nerve Tissue Proteins; Norepinephrine; Nucleus Accumbens; Peptide Fragments; Phenylethyl Alcohol; Reward; Tissue Culture Techniques | 2017 |
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; alpha-Synuclein; Antioxidants; Cell Line; Copper; Dopamine; Humans; Monoamine Oxidase; Monophenol Monooxygenase; Oligodendroglia; Oxidation-Reduction; Parkinson Disease; Protein Binding; Protein Conformation; Tolcapone | 2020 |